ArticleJournal of neurosurgery. Pediatrics2025
Revisiting the Endoscopic Third Ventriculostomy Success Score using machine learning: can we do better?
Article in Journal of neurosurgery. Pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Machine learning for endoscopic third ventriculostomy success prediction-a systematic review and meta-analysis.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2025Pooled it
- Evaluation of the endoscopic third ventriculostomy success score for stereotactic prepontine stenting in patients with aqueductal stenosis.Brain & spine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
objectiveThe Endoscopic Third Ventriculostomy Success Score (ETVSS) is a useful decision-making heuristic when considering the probability of surgical success, defined traditionally as no repeat cerebrospinal fluid diversion surgery needed within 6 months. Nonetheless, the performance of the logistic regression (LR) model in the original 2009 study was modest, with an area under the receiver operating characteristic curve (AUROC) of 0.68. The authors sought to use a larger dataset to develop more accurate machine learning (ML) models to predict endoscopic third ventriculostomy (ETV) success and also to perform the largest validation of the ETVSS to date.
methodsThe authors queried the MarketScan national database for the years 2005-2022 to identify patients < 18 years of age who underwent first-time ETV and subsequently had at least 6 months of continuous enrollment in the database. The authors collected data on predictors matching the original ETVSS: age, etiology of hydrocephalus, and history of any previous shunt placement. Next, they used 6 ML algorithms-LR, support vector classifier, random forest, k-nearest neighbors, Extreme Gradient Boosted Regression (XGBoost), and naive Bayes-to develop predictive models. Finally, the authors used nested cross-validation to assess the models' comparative performances on unseen data.
resultsThe authors identified 2047 patients who met inclusion criteria, and 1261 (61.6%) underwent successful ETV. The performances of most ML models were similar to that of the original ETVSS, which had an AUROC of 0.693 on the validation set and 0.661 (95% CI 0.600-0.722) on the test set. The authors' new LR model performed comparably with AUROCs of 0.693 on both the validation and test sets, with 95% CI 0.633-0.754 on the test set. Among the more complex ML algorithms, XGBoost performed best, with AUROCs of 0.683 and 0.672 (95% CI 0.609-0.734) on the validation and test sets, respectively.
conclusionsThis is the largest external validation of the ETVSS, and it confirms modest performance. More sophisticated ML algorithms do not meaningfully improve predictive performance compared to ETVSS; this underscores the need for higher utility, novelty, and dimensionality of input data rather than changes in modeling strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.